These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19132059)

  • 1. Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine.
    Nakano H; Omura S
    J Antibiot (Tokyo); 2009 Jan; 62(1):17-26. PubMed ID: 19132059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles.
    Sánchez C; Salas AP; Braña AF; Palomino M; Pineda-Lucena A; Carbajo RJ; Méndez C; Moris F; Salas JA
    Chem Commun (Camb); 2009 Jul; (27):4118-20. PubMed ID: 19568652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New indolocarbazoles as antitumour active compounds: evaluation of the target by experimental and theoretical studies.
    Marotto A; Kim YS; Schulze E; Pindur U
    Pharmazie; 2002 Mar; 57(3):194-7. PubMed ID: 11933850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indolocarbazole antitumour compounds by combinatorial biosynthesis.
    Salas JA; Méndez C
    Curr Opin Chem Biol; 2009 Apr; 13(2):152-60. PubMed ID: 19251468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium complexes as protein kinase inhibitors.
    Zhang L; Carroll P; Meggers E
    Org Lett; 2004 Feb; 6(4):521-3. PubMed ID: 14961613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase inhibition of clinically important staurosporine analogues.
    Gani OA; Engh RA
    Nat Prod Rep; 2010 Apr; 27(4):489-98. PubMed ID: 20336234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthesis of bioactive indolocarbazoles related to K-252a.
    Moffat D; Nichols CJ; Riley DA; Simpkins NS
    Org Biomol Chem; 2005 Aug; 3(16):2953-75. PubMed ID: 16186927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering biosynthetic pathways to generate antitumor indolocarbazole derivatives.
    Sánchez C; Méndez C; Salas JA
    J Ind Microbiol Biotechnol; 2006 Jul; 33(7):560-8. PubMed ID: 16491358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA binding properties of the indolocarbazole antitumor drug NB-506.
    Carrasco C; Vezin H; Wilson WD; Ren J; Chaires JB; Bailly C
    Anticancer Drug Des; 2001; 16(2-3):99-107. PubMed ID: 11962518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staurosporine-based binding assay for testing the affinity of compounds to protein kinases.
    Iyer GH; Taslimi P; Pazhanisamy S
    Anal Biochem; 2008 Feb; 373(2):197-206. PubMed ID: 18047825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified staurosporine analogs as potent JAK3 inhibitors.
    Yang SM; Malaviya R; Wilson LJ; Argentieri R; Chen X; Yang C; Wang B; Cavender D; Murray WV
    Bioorg Med Chem Lett; 2007 Jan; 17(2):326-31. PubMed ID: 17088059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitors.
    Li Z; Zhai F; Zhao L; Guo Q; You Q
    Bioorg Med Chem Lett; 2009 Jan; 19(2):406-9. PubMed ID: 19058964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial biosynthesis of antitumor indolocarbazole compounds.
    Sánchez C; Zhu L; Braña AF; Salas AP; Rohr J; Méndez C; Salas JA
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):461-6. PubMed ID: 15625109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TrkA kinase inhibitors from a library of modified and isosteric Staurosporine aglycone.
    Tripathy R; Angeles TS; Yang SX; Mallamo JP
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3551-5. PubMed ID: 18508265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tethering small molecules to a phage display library: discovery of a selective bivalent inhibitor of protein kinase A.
    Meyer SC; Shomin CD; Gaj T; Ghosh I
    J Am Chem Soc; 2007 Nov; 129(45):13812-3. PubMed ID: 17944472
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthetic studies on indolocarbazoles: total synthesis of staurosporine aglycon.
    Rajeshwaran GG; Mohanakrishnan AK
    Org Lett; 2011 Mar; 13(6):1418-21. PubMed ID: 21341756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiamoebic Activities of Indolocarbazole Metabolites Isolated from
    Cartuche L; Reyes-Batlle M; Sifaoui I; Arberas-Jiménez I; Piñero JE; Fernández JJ; Lorenzo-Morales J; Díaz-Marrero AR
    Mar Drugs; 2019 Oct; 17(10):. PubMed ID: 31627366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel fluorescent probe for fluorescence correlation spectroscopic detection of kinase inhibitors.
    Kawaguchi M; Terai T; Utata R; Kato M; Tsuganezawa K; Tanaka A; Kojima H; Okabe T; Nagano T
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3752-5. PubMed ID: 18524589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indolocarbazole natural products: occurrence, biosynthesis, and biological activity.
    Sánchez C; Méndez C; Salas JA
    Nat Prod Rep; 2006 Dec; 23(6):1007-45. PubMed ID: 17119643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolocarbazoles as checkpoint 1 kinase inhibitors.
    Hénon H; Conchon E; Hugon B; Messaoudi S; Golsteyn RM; Prudhomme M
    Anticancer Agents Med Chem; 2008 Aug; 8(6):577-97. PubMed ID: 18690823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.